A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer

Clinical trial NCT02276027 · COMPLETED

Trial details

NCT number: NCT02276027
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma

Start date: 2015-01-20
Primary completion: 2019-10-15
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.